In light of these findings, we postulate that B002T‐LP004 recruited immune cells from the peripheral blood to the tumor tissue, whereas the remaining T, B, NK, NKT, and other cells in the peripheral blood were still activated by B002T‐LP004 (Figure S4A), IFN‐γ, KC, TNFα, MCP‐1, IL‐12p70RANTES, IL‐1β, IP‐10, GM‐CSF, IFN‐β, and IFN‐α in the peripheral blood of the mice in the ISAC administration group. The gene discussed is CCL2; the disease is neoplasm.